Literature Review
The number of family caregivers helping older US adults increased from 18 million to 24 million, 2011–22
02/17/25 at 03:00 AMThe number of family caregivers helping older US adults increased from 18 million to 24 million, 2011–22 Health Affairs; by Jennifer L. Wolff, Jennifer C. Cornman, and Vick A. Freedman; 2/25 The evolving composition and experiences of the family caregiver workforce have profound ramifications for public policy but are not well understood. Drawing on the linked National Health and Aging Trends Study and National Study of Caregiving, we found that the numbers of family caregivers providing help to older adults increased by nearly six million between 2011 and 2022, rising from 18.2 million to 24.1 million. ... For family caregivers as a whole, challenges persist, and for those assisting people with dementia, tailored surveillance and effective support programs are needed.
Class action over UHG's alleged AI-driven care denials advances
02/17/25 at 03:00 AMClass action over UHG's alleged AI-driven care denials advances Modern Healthcare; by Lauren Berryman; 2/13/25 A class action regarding UnitedHealthcare’s alleged use of artificial intelligence to deny care for Medicare Advantage members will continue playing out in court, but with fewer claims. In a court filing Thursday, a federal judge said two of seven claims brought against UnitedHealth Group by health plan members and their families — who alleged the company used AI to deny coverage for medically necessary post-acute care — can move forward. UnitedHealth Group has been battling the lawsuit, filed in the U.S. District Court for the District of Minnesota, since November 2023. Plaintiffs have alleged the company's health insurance unit UnitedHealthcare used an AI tool called nH Predict to make coverage decisions, sometimes overriding physician judgment.
UnitedHealth, Amedisys plan divesture of up to 128 locations
02/17/25 at 03:00 AMUnitedHealth, Amedisys plan divesture of up to 128 locations Modern Healthcare; by Diane Eastabrook; 2/11/25 UnitedHealth Group said in a court filing Friday [2/7/25] its plans to sell at least 128 home health and hospice locations to ease the Justice Department's antitrust concerns around its acquisition of Amedisys. The divestiture plans were part of a filing in the United States District Court for the District of Maryland in a response to the Justice Department’s lawsuit to block the proposed acquisition. ... The company didn’t identify which locations would be sold, but said they would be in areas where UnitedHealth Group and Amedisys’ combined market share would exceed the thresholds federal regulators allege could harm competition. UnitedHealth Group said in the court filing it was in the process of identifying qualified buyers who would be able to operate and grow the divested locations.
Hospice leaders applaud CMS’s decision to reevaluate Special Focus Program, call for meaningful reforms
02/17/25 at 02:00 AMHospice leaders applaud CMS’s decision to reevaluate Special Focus Program, call for meaningful reforms National Alliance for Care at Home, Washington, DC and Alexandria, VA; Press Release; 2/14/25 Effective February 14, 2025, the Centers for Medicare & Medicaid Services (CMS) has ceased the implementation of the Hospice Special Focus Program (SFP) so that CMS may further evaluate the program. This decision is a positive move acknowledging that the current approach is not working as intended. The hospice community has long advocated for strong oversight and patient protections, but the SFP, as implemented, was deeply flawed, unlawful, and harmful to the very patients it was meant to protect. A multi-state coalition of hospices and hospice associations took legal action in January to challenge the program, citing its misrepresentation of hospice compliance records, misleading data, and jeopardized access to high-quality end-of-life care. The flawed algorithm behind the SFP failed to distinguish fraudulent providers from reputable ones, disproportionately penalized well-established hospices, and ignored repeated warnings from congressional leaders and industry stakeholders. ... Now that CMS is reassessing its approach, there is an opportunity to ensure that oversight efforts truly enhance patient protections without restricting access to trusted hospice providers. The National Alliance for Care at Home (the Alliance) and the National Partnership for Healthcare and Hospice Innovation (NPHI) remain committed to protecting access to high-quality hospice care and ensuring that regulatory oversight is fair, transparent, and aligned with congressional intent. ... [Click on the title's link to continue reading.]
In the wake of California fires, a hospice opens its arms to help a community heal
02/16/25 at 03:55 AMIn the wake of California fires, a hospice opens its arms to help a community heal Pasadena Now, Pasadena, CA; 2/8/25 A Los Angeles hospice organization announced Thursday it has extended its expertise in grief counseling to help residents process the collective trauma of the recent destructive wildfires. In the Arms of Grace Hospice, based in Los Feliz, will begin offering free weekly drop-in support groups for those affected by the Eaton and Palisades fires starting February 4. The open-format sessions at St. Gregory Church in Pasadena will be led by Dr. Ani Karayan, PhD, a clinical psychologist with more than two decades of experience in trauma-informed care. “The fires have caused significant disruption in the lives of many in the community,” said Kevin Tutunjian, president of In the Arms of Grace Hospice. “We wanted to create a safe and supportive space that validates the complex and nuanced emotions this community is going through.”
Suzetrigine: First-in-class nonopioid pain therapy is approved by FDA
02/16/25 at 03:50 AMSuzetrigine: First-in-class nonopioid pain therapy is approved by FDAAmerican Journal of Managed Care; Giuliana Grossi; 1/25Suzetrigine (Journavx; Vertex Pharmaceuticals) received approval from the FDA for the treatment of adults with moderate-to-severe acute pain, according to an announcement from Vertex. The therapy is a novel oral, non-opioid, highly selective NaV1.8 pain signal inhibitor ... offering a non-opioid alternative amid the opioid crisis. Clinical trials demonstrated significant efficacy in postsurgical pain relief, though results varied across different conditions. Despite this, suzetrigine offers the potential to energize the nonopioid pain market, which includes other companies like Tris Pharma, Latigo Biotherapeutics, and SiteOne Therapeutics—all actively developing alternatives to opioids. Key findings from the Institute for Clinical and Economic Review analysis of the phase 3 trials include potential lifetime cost savings of $200 per patient when comparing suzetrigine with opioids, assuming a 1-week course priced at $420.
What is renal cell carcinoma?
02/16/25 at 03:45 AMWhat is renal cell carcinoma?JAMA; Rebecca Voelker, MSJ; 1/25Renal cell carcinoma is a common cancer that forms in the kidneys. In 2023, an estimated 81,800 people were diagnosed with renal cell carcinoma in the US, making it the sixth most common cancer among males and the ninth among females. Renal cell carcinoma is most often diagnosed in people aged 60 to 70 years. Although the diagnosis has increased slightly in the US in recent years, deaths from renal cell carcinoma have declined. Although the survival rate of stage IV renal cell carcinoma varies among individuals, the average 5-year survival is 28%.
Researchers outline new research priorities in neuropalliative care
02/16/25 at 03:40 AMResearchers outline new research priorities in neuropalliative care UNC Health and UNC School of Medicine, Chapel Hill, NC; by Winnie K. Lau, MD and David Y. Hwang, MD2/7/25... An emerging field, termed “neuropalliative care,” has taken shape over the past few years to help provide impactful, holistic care for patients with serious neurological disease. And now, experts in the field are seeking ways to improve the overall wellbeing of their patients and loved ones through the power of research. ... A special communication in JAMA Neurology, first-authored by Winnie K. Lau, MD, a neurocritical care physician and associate professor of neurology and senior-authored by David Y. Hwang, MD, professor of neurology and division chief of neurocritical care, describes needed research that can help advance patient care, including:
Learning from death: New memoir If We Never Meet Again imparts lessons from working with hospice patients
02/16/25 at 03:35 AMLearning from death: New memoir If We Never Meet Again imparts lessons from working with hospice patientsThe MarCom Journal, Charleston, SC; by Globe Newswire; 2/6/25While the topic of death is generally considered taboo, English teacher turned hospice administrator Matthew Cornett believes there is much to be learned from death. After becoming an empty nester, Cornett left the classroom behind and began a second career in hospice care. And the more time he spent with people as they approached the end of their life, the more he realized that their deaths had meaning. And what emerged from those final moments was something profound. Hoping to make others feel more comfortable when it comes to preparing for and talking about death, he presents a memoir of his journey into the world of hospice care. In If We Never Meet Again, Cornett chronicles his experiences providing compassion and support to hospice patients while adjusting to his new role. Finding inspiration in his patient’s “death stories,” he found himself on an unexpected path of self-discovery. Cornett’s personal reflections on these intimate and emotional interactions encourage readers to reconsider how they view death and dying.
Palliative care initiated in the Emergency Department-A cluster randomized clinical trial
02/16/25 at 03:30 AMPalliative care initiated in the Emergency Department-A cluster randomized clinical trialJAMA; Corita R. Grudzen, MD, MSHS; Nina Siman, MA, MSEd; Allison M. Cuthel, MPH; Oluwaseun Adeyemi, MBBS, PhD; Rebecca Liddicoat Yamarik, MD; Keith S. Goldfeld, DrPH, MS, MPA; PRIM-ER Investigators; 1/25Question-What is the effect of a multicomponent intervention to initiate palliative care in the emergency department on hospital admission in older adults with serious, life-limiting illness? In this cluster randomized clinical trial, which was conducted at 29 US emergency departments and included 98,922 initial visits, there was no difference in the rate of hospital admission in older adults with serious, life-limiting illness receiving care before (64.4%) vs after (61.3%) emergency department clinical staff receipt of a multicomponent primary palliative care intervention. Relevance-This multicomponent intervention to initiate palliative care in the ED did not have an effect on hospital admission, subsequent health care use, or short-term mortality in older adults with serious, life-limiting illness.
Palliative care program for community-dwelling individuals with dementia and caregivers: The IN-PEACE randomized clinical trial
02/16/25 at 03:25 AMPalliative care program for community-dwelling individuals with dementia and caregivers: The IN-PEACE randomized clinical trialJAMA Network; by Greg A. Sachs, Nina M. Johnson, Sujuan Gao, Alexia M. Torke, Susan E. Hickman, Amy Pemberton, Andrea Vrobel, Minmin Pan, Jennifer West, Kurt Kroenke; 1/25Among community-dwelling individuals with moderate to severe dementia, does a dementia care management program with integrated palliative care reduce patients’ neuropsychiatric symptoms? In this randomized clinical trial, a dementia care management program with integrated palliative care did not significantly improve patients’ neuropsychiatric symptoms.
Arkansas Hospice names Brian Bell new President and CEO
02/16/25 at 03:20 AMArkansas Hospice names Brian Bell new President and CEO Arkansas Money & Politics (AMP); by AMP Staff; 2/7/25 Arkansas Hospice announced Thursday that Dr. Brian W. Bell, M.D., FAAHPM, will take over as president and CEO for Arkansas Hospice’s Family of Care on March 10. He joined the company in 2016 and is currently the chief medical officer. He will replace Judith Wooten, who announced her retirement last year. Wooten will stay on through April to ensure a smooth transition. Bell has worked in hospice care since 2006 and is board-certified in family medicine and hospice and palliative medicine. He is one of only people in the state with the designation fellow of the Academy of Hospice and Palliative Medicine.
Access tops list of Americans' healthcare concerns: 4 survey findings
02/16/25 at 03:15 AMAccess tops list of Americans' healthcare concerns: 4 survey findings Becker's Clinical Leadership; by Erica Carbajal; 2/5/25A quarter of Americans rank healthcare access and affordability as the top public health priority they want government leaders to focus on, according to poll findings from Gallup and Emory University's Rollins School of Public Health. ... Four key findings:
Flu cases continue to rise across the country
02/16/25 at 03:10 AMFlu cases continue to rise across the countryABC 6 News, Rochester, MN; by KAALTV; 2/10/25Flu cases are continuing to rise across the country as doctor visits for flu-like symptoms are now reaching their highest point in 15 years. The CDC estimates at least 24 million illnesses this flu season alone, with 13,000 turning deadly. Right now, about 31% of flu tests are coming back positive, nearly double the peak from last season. Doctors say your best line of defense is vaccination. Editor's note: We see this surge across news media sources, and compiled this state-specific list for you.
HealthcareBusinessToday.com series on hospice care
02/16/25 at 03:05 AMHealthcareBusinessToday.com series on hospice careEditor's note: The following community education articles about hospice care were posted by HealthcareBusinessToday.com on 2/10/25.
Today's Encouragement
02/16/25 at 03:00 AMStopping by woods on a snowy evening ...The woods are lovely, dark and deep, But I have promises to keep, And miles to go before I sleep, And miles to go before I sleep. By Robert Frost [click on the link above for the entire poem]
New report details financial, emotional toll of Parkinson’s on family caregivers
02/16/25 at 03:00 AMNew report details financial, emotional toll of Parkinson’s on family caregivers McKnights Home Care; by Foster Stubbs; 2/4/25 A new report sheds a light on the unique challenges faced by family caregivers who care for loved ones with Parkinson’s disease (PD). The report, Parkinson’s Disease Caregiving in the US, features insights from secondary analysis and supplementary interviews with 10 PD caregivers. These caregivers average 31 hours of unpaid care per week; half of interviewed caregivers exceed 100 hours each week, according to the report. The National Alliance for Caregiving (NAC), with support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Arcadia University, released the report.
Today's Encouragement
02/15/25 at 03:55 AMKeep your face always toward the sunshine—and shadows will fall behind you. ~Walt Whitman
Long-term health care use among children surviving multiple organ dysfunction
02/15/25 at 03:40 AMLong-term health care use among children surviving multiple organ dysfunctionJAMA Network Open; Robert Ohman, MD, MPH; Jerry J. Zimmerman, MD, PhD; 1/25Mortality outcomes of pediatric critical illness have improved over the last several decades, while concurrently the population of patients with technology dependency and complex chronic morbidities has continued to grow and the incidence of MOD [multiple organ dysfunction] has simultaneously increased. In the setting of declining critical illness mortality, pediatric outcomes research has broadened its scope to assess metrics beyond mortality, describing the trajectory of recovery from critical illness with measures of patient quality of life; physical, cognitive, and functional status; and family psychological and economic well-being. As the authors point out, assessment of the larger financial impact of this higher health care utilization on families themselves would be valuable future knowledge, as high health care utilization, appointments, and recurrent hospitalizations may detract from families’ ability to work, care for their other children, and attend to their own medical needs. Targeted support for families of survivors of MOD may be necessary to minimize these secondary impacts and to optimize outcomes for this vulnerable population of patients.
Compassion in the justification of physician-assisted dying: Gandhi’s non-violence vs. Aristotle’s virtues and vices
02/15/25 at 03:40 AMCompassion in the justification of physician-assisted dying: Gandhi’s non-violence vs. Aristotle’s virtues and vicesMedicine, Health Care and Philosophy; Ercan Avci; 1/25Compassion is an essential phenomenon in the therapeutic relationship, and some use it to justify physician-assisted dying practices. However, different approaches to its definition and scope can lead to distinct conclusions about the role of compassion in end-of-life interventions. In this context, the paper aims to compare Mahatma Gandhi’s and Aristotle’s views on compassion to explore whether it can be utilized to justify physician-assisted dying. Gandhi’s thoughts on compassion and Aristotle’s standpoint on virtues and vices demonstrate that Gandhi evaluates this concept as a moral duty to relieve intractable suffering, whereas Aristotle relies on balancing all virtues through relevant deficiencies and excesses. Therefore, even though Gandhi’s opinion on compassion can for allow assisted dying interventions, Aristotle’s idea of virtues and vices restricts compassion to a scope that alleviates suffering through available means without causing death.
Brain biomarkers for pain sensitivity
02/15/25 at 03:25 AMBrain biomarkers for pain sensitivityJAMA Neurology; Prasad Shirvalkar, MD, PhD; Christopher J. Rozell, PhD; 1/25Identifying objective biomarkers that track individual pain severity has been dubbed “the holy grail” of pain neuroscience. Chronic pain affects up to one-fifth of US adults, and its complexity is attributed to a confluence of physical, emotional, and cognitive factors that contribute to suffering and disability. The epidemic of chronic pain initially contributed to the rise of the opioid epidemic and continues to plague nearly all fields of clinical medicine. Identifying and validating biomarkers to predict individual risk for chronic pain facilitate a precision medicine approach to pain medicine. Despite the unknown provenance of the proposed biomarkers, the results of the present study have the potential to aid in the practical development of personalized pain management strategies.
Lived experiences of patients hospitalized with acute decompensated heart failure and kidney dysfunction
02/15/25 at 03:25 AMLived experiences of patients hospitalized with acute decompensated heart failure and kidney dysfunctionJAMA Network Open; Gwen M. Bernacki, MD, MHSA; Ann M. O’Hare, MD, MA; Mahlet Assefa, MD; Kevin D. O’Brien, MD; David K. Prince, PhD; James N. Kirkpatrick, MD; Nisha Bansal, MD, MAS; Catherine R. Butler, MD, MA; 1/25This qualitative study of patients currently or recently hospitalized with ADHF [acute decompensated heart failure] and kidney dysfunction offers a window on the lived experiences of members of this medically vulnerable group. Study participants offered vivid accounts of how their illness had impacted their day-to-day lives, sense of self, life priorities, and hopes and expectations for the future. However, many lacked a detailed understanding of the medical aspects of their illness and did not always feel equipped or empowered to actively participate in their care. Our findings suggest that there may be untapped opportunities to improve quality of communication for patients with ADHF and kidney dysfunction.
Reimagining care and research for Amyotrophic Lateral Sclerosis
02/15/25 at 03:15 AMReimagining care and research for Amyotrophic Lateral SclerosisJAMA Neurology; Suma Babu, MBBS, MPH; Joshua M. Sharfstein, MD; Eva L. Feldman, MD, PhD; 1/25Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease involving progressive motor neuron degeneration. In 2022, US Congress and the National Institutes of Health (NIH) commissioned the National Academies of Science, Engineering and Medicine (NASEM) to identify priorities to make ALS a livable disease within a decade. After extensive deliberations and input from the public, researchers, and persons with lived experience, the committee released its report, Living With ALS. To accelerate progress in patient care and therapeutics, one of the report’s major recommendations was for the National Institute of Neurological Disorders and Stroke (NINDS) to fund a clinical trials network dedicated to ALS that is distributed across diverse geographic regions and integrated within a novel hub-and-spoke system of care and research for ALS. The hubs are ALS Centers of Excellence that provide patient care and research, both basic and clinical, while the spokes represent a large number of community and regional ALS clinics that provide care and link to hubs for research. By integrating ALS clinical trials within this structure, we have the potential to transform ALS care, drive innovation in ALS therapeutic development, and pave the way for breakthroughs in other neurodegenerative diseases.
Sudden unexpected infant death and disparities in infant mortality in the US, 1999-2022
02/15/25 at 03:15 AMSudden unexpected infant death and disparities in infant mortality in the US, 1999-2022JAMA Pediatrics; Elizabeth R. Wolf, MD, MPH; Frederick P. Rivara, MD, MPH; Anabeel Sen, MBBS, MPH; Steven H. Woolf, MD, MPH; 1/25This study found that infant mortality from SUID [sudden unexpected infant death] has increased significantly. Previous data through 2020 showed that SUID increased among Black infants. Our analysis, which included 2021 and 2022 data, showed a more generalized increase. Possible explanations include COVID-19 or other respiratory illnesses, maternal opioid use, and social media’s influence on infant sleeping practices. SUID mortality rates were notably higher among American Indian or Alaska Native, Black, and Native Hawaiian or Other Pacific Islander infants than among Asian and White infants. Disparities in SUID could reflect unsafe sleeping position, prematurity, tobacco exposure, and/or infant feeding practices; further research is needed.
Impact of inpatient palliative care on end-of-life care among patients with early-onset colorectal cancer
02/15/25 at 03:10 AMImpact of inpatient palliative care on end-of-life care among patients with early-onset colorectal cancerJournal of Clinical Oncology; Suriya Baskar, Bohae R Lee, Rajiv Midha, Udhayvir Singh Grewal; 1/25Palliative care has proven benefits in elderly patients with advanced cancer; however, the objective benefits of palliative care in younger patients with cancer remain under-studied. We sought to examine the impact of inpatient palliative care consultation on end-of-life (EOL) care among hospitalized patients with early-onset colorectal cancer (EO-CRC). Inpatient palliative care consultation at EOL among patients with EOCRC was associated with lesser use of aggressive interventions and higher rates of DNR code status. We also noted significantly lower costs of hospitalization among patients receiving inpatient palliative care consultation at EOL. These results underscore the importance of integration of inpatient palliative care consultation among patients with EOCRC at EOL.